Mechanisms and functions of p38 MAPK signalling.

The p38 MAPK (mitogen-activated protein kinase) signalling pathway allows cells to interpret a wide range of external signals and respond appropriately by generating a plethora of different biological effects. The diversity and specificity in cellular outcomes is achieved with an apparently simple linear architecture of the pathway, consisting of a core of three protein kinases acting sequentially. In the present review, we dissect the molecular mechanisms underlying p38 MAPK functions, with special emphasis on the activation and regulation of the core kinases, the interplay with other signalling pathways and the nature of p38 MAPK substrates as a source of functional diversity. Finally, we discuss how genetic mouse models are facilitating the identification of physiological functions for p38 MAPKs, which may impinge on their eventual use as therapeutic targets.

[1]  Jonathan A. Cooper,et al.  Phosphorylation of mammalian eIF4E by Mnk1 and Mnk2: tantalizing prospects for a role in translation. , 2001, Progress in molecular and subcellular biology.

[2]  A. Tall,et al.  Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. , 2009, The Journal of clinical investigation.

[3]  Gabriella De Vita,et al.  p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .

[4]  Roger J. Davis,et al.  Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.

[5]  M. Cotten,et al.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Jiahuai Han,et al.  MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α , 2002, Science.

[7]  P. Rao,et al.  RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways , 2009, Proteomics.

[8]  E. Appella,et al.  Alternative p38 activation pathway mediated by T cell receptor–proximal tyrosine kinases , 2005, Nature Immunology.

[9]  Dustin E. Schones,et al.  Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. , 2009, Cell stem cell.

[10]  Philip R. Cohen,et al.  Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.

[11]  H. Osada,et al.  Exip, a splicing variant of p38α, participates in interleukin‐1 receptor proximal complex and downregulates NF‐κB pathway , 2004 .

[12]  W. P. Wahls,et al.  Phosphorylation-Independent Regulation of Atf1-Promoted Meiotic Recombination by Stress-Activated, p38 Kinase Spc1 of Fission Yeast , 2009, PloS one.

[13]  Jukka Westermarck,et al.  Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  B. Shen,et al.  Novel strategies for inhibition of the p38 MAPK pathway. , 2007, Trends in pharmacological sciences.

[15]  G. Haegeman,et al.  Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.

[16]  A. Nebreda,et al.  Regulation of Tumorigenesis by p38 α MAP Kinase , 2007 .

[17]  S. Tapscott,et al.  p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation , 2007, Nature Structural &Molecular Biology.

[18]  P. Graves,et al.  Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. , 2008, The Biochemical journal.

[19]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[20]  M. Karin,et al.  Requirement for p38α in Erythropoietin Expression A Role for Stress Kinases in Erythropoiesis , 2000, Cell.

[21]  A. Porras,et al.  p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.

[22]  J. Ninomiya-Tsuji,et al.  AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart , 2005, Circulation research.

[23]  Dan Yang,et al.  Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-alpha-induced endothelial barrier dysfunction and apoptosis. , 2010, Cardiovascular research.

[24]  J. Chrivia,et al.  The Chromatin Remodeling Protein, SRCAP, Is Critical for Deposition of the Histone Variant H2A.Z at Promoters* , 2007, Journal of Biological Chemistry.

[25]  Yibin Wang,et al.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. , 2005, Genes & development.

[26]  Michel Morange,et al.  A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins , 1994, Cell.

[27]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[28]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[29]  C. Pargellis,et al.  Discovery and characterization of a substrate selective p38alpha inhibitor. , 2004, Biochemistry.

[30]  J. Ashwell,et al.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production. , 2009, Blood.

[31]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[32]  P. Crespo,et al.  Phosphorylation of p38 by GRK2 at the Docking Groove Unveils a Novel Mechanism for Inactivating p38MAPK , 2006, Current Biology.

[33]  M. Rudnicki,et al.  Jcb: Article , 2022 .

[34]  C. Lowenstein,et al.  Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling , 2008, The Journal of experimental medicine.

[35]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[36]  J. Arthur,et al.  p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice. , 2009, Cancer research.

[37]  R. Klein,et al.  Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. , 2000, Molecular cell.

[38]  P. Cohen,et al.  Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.

[39]  Yong Jiang,et al.  Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.

[40]  Emma Black,et al.  Negative Feedback Regulation of MKK6 mRNA Stability by p38α Mitogen-Activated Protein Kinase , 2003, Molecular and Cellular Biology.

[41]  R. Flavell,et al.  p38 MAPK Autophosphorylation Drives Macrophage IL-12 Production during Intracellular Infection1 , 2005, The Journal of Immunology.

[42]  Jemma L. Webber,et al.  Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IP , 2010, The EMBO journal.

[43]  Jiahuai Han,et al.  Macrophage Deletion of p38α Partially Impairs Lipopolysaccharide-Induced Cellular Activation1 , 2008, The Journal of Immunology.

[44]  Ricardo M Biondi,et al.  Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. , 2003, The Biochemical journal.

[45]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[46]  J. Yun,et al.  Akt2, but not Akt1, is required for cell survival by inhibiting activation of JNK and p38 after UV irradiation , 2009, Oncogene.

[47]  B. Cuevas,et al.  Role of mitogen-activated protein kinase kinase kinases in signal integration , 2007, Oncogene.

[48]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[49]  A. Cuadrado,et al.  Essential role of p18Hamlet/SRCAP‐mediated histone H2A.Z chromatin incorporation in muscle differentiation , 2010, The EMBO journal.

[50]  M. Merchant,et al.  Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex* , 2007, Journal of Biological Chemistry.

[51]  E. Goldsmith,et al.  Determinants That Control the Specific Interactions between TAB1 and p38α , 2006, Molecular and Cellular Biology.

[52]  M. Karin,et al.  The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. , 2001, Molecular cell.

[53]  Marilyn A Huestis,et al.  Modern analytical technologies for the detection of drug abuse and doping. , 2006, Drug discovery today. Technologies.

[54]  Jian Du,et al.  A Novel Role of p38α MAPK in Mitotic Progression Independent of Its Kinase Activity , 2005 .

[55]  Jiahuai Han,et al.  Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. , 2000, Genes & development.

[56]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[57]  R. Davis,et al.  Regulation of MAP kinases by docking domains , 2001, Biology of the cell.

[58]  W. Langdon,et al.  A TNF- and c-Cbl-dependent FLIPS-degradation pathway and its function in Mycobacterium tuberculosis–induced macrophage apoptosis , 2009, Nature Immunology.

[59]  S. Burchill,et al.  p38(MAPK): stress responses from molecular mechanisms to therapeutics. , 2009, Trends in molecular medicine.

[60]  P. Cohen,et al.  Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. , 1999, The Journal of biological chemistry.

[61]  P. Cohen,et al.  A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosis , 2007, The EMBO journal.

[62]  Eulàlia de Nadal,et al.  Osmostress‐induced transcription by Hot1 depends on a Hog1‐mediated recruitment of the RNA Pol II , 2003, The EMBO journal.

[63]  G. Wani,et al.  The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation* , 2008, Journal of Biological Chemistry.

[64]  R. Flavell,et al.  Diverse Mechanisms of Myocardial p38 Mitogen-Activated Protein Kinase Activation: Evidence for MKK-Independent Activation by a TAB1-Associated Mechanism Contributing to Injury During Myocardial Ischemia , 2003, Circulation research.

[65]  Jiahuai Han,et al.  TAB-1 Modulates Intracellular Localization of p38 MAP Kinase and Downstream Signaling* , 2006, Journal of Biological Chemistry.

[66]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[67]  Bennett T. Farmer,et al.  Molecular basis of MAPK-activated protein kinase 2:p38 assembly , 2007, Proceedings of the National Academy of Sciences.

[68]  R. Derynck,et al.  Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. , 2010, Molecular cell.

[69]  Zhi-Xin Wang,et al.  Enzymatic Activity and Substrate Specificity of Mitogen-activated Protein Kinase p38α in Different Phosphorylation States* , 2008, Journal of Biological Chemistry.

[70]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[71]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[72]  Arthur Js MSK activation and physiological roles. , 2008 .

[73]  A. Cuadrado,et al.  p18Hamlet Mediates Different p53-Dependent Responses to DNA Damage Inducing Agents , 2007, Cell cycle.

[74]  She Chen,et al.  Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. , 2007, Molecular cell.

[75]  Arthur J. Olson,et al.  p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. , 2009, Journal of molecular biology.

[76]  T. Mustelin,et al.  Regulation of the Ring Finger E3 Ligase Siah2 by p38 MAPK* , 2006, Journal of Biological Chemistry.

[77]  Xudong Liang,et al.  Anthrax Lethal Factor Proteolysis and Inactivation of MAPK Kinase* , 2003, The Journal of Biological Chemistry.

[78]  Cihan Çetin,et al.  Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. , 2009, Nature chemical biology.

[79]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[80]  Jay C. Sy,et al.  Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. , 2008, Nature materials.

[81]  Jong-Sun Kang,et al.  Cdo promotes neuronal differentiation via activation of the p38 mitogen‐activated protein kinase pathway , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  M. Gaestel,et al.  The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK , 2006, Molecular and Cellular Biology.

[83]  Liang Tong,et al.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002 .

[84]  N. Silverman,et al.  Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli. , 2006, Cellular signalling.

[85]  M. Gaestel,et al.  Leptomycin B‐sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation , 1998, The EMBO journal.

[86]  M. Haine,et al.  Van Damme A. , 1986 .

[87]  K. Wilson,et al.  The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. , 1999, Structure.

[88]  M. Zerial,et al.  Phosphorylation of EEA1 by p38 MAP kinase regulates μ opioid receptor endocytosis , 2005, The EMBO journal.

[89]  M. Barbacid,et al.  p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation , 2007, Nature Genetics.

[90]  C. Heldin,et al.  The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.

[91]  Sin-Hye Oh,et al.  Glutamine Protects Mice from Lethal Endotoxic Shock via a Rapid Induction of MAPK Phosphatase-11 , 2009, The Journal of Immunology.

[92]  P. Crespo,et al.  Mxi2 promotes stimulus‐independent ERK nuclear translocation , 2007, The EMBO journal.

[93]  M. Goedert,et al.  SAP kinase‐3, a new member of the family of mammalian stress‐activated protein kinases , 1996, FEBS letters.

[94]  R. Mayer,et al.  p38 MAP kinase inhibitors: A future therapy for inflammatory diseases , 2006 .

[95]  J. Rojas,et al.  Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38α Mitogen-Activated Protein Kinase via Sprouty2 Downregulation , 2009, Molecular and Cellular Biology.

[96]  S. Srikantan,et al.  Increased MKK4 Abundance with Replicative Senescence Is Linked to the Joint Reduction of Multiple MicroRNAs , 2009, Science Signaling.

[97]  Dan Yang,et al.  Erratum to: Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-α-induced endothelial barrier dysfunction and apoptosis , 2010 .

[98]  C. Marshall,et al.  Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 , 1998, Current Biology.

[99]  J. Mudgett,et al.  Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Eulàlia de Nadal,et al.  Multilayered control of gene expression by stress‐activated protein kinases , 2010, The EMBO journal.

[101]  C. Goding,et al.  Target Gene Specificity of USF-1 Is Directed via p38-mediated Phosphorylation-dependent Acetylation* , 2009, The Journal of Biological Chemistry.

[102]  I. Mellman,et al.  Defective IL‐12 production in mitogen‐activated protein (MAP) kinase kinase 3 (Mkk3)‐deficient mice , 1999, The EMBO journal.

[103]  R. Flavell,et al.  A non‐redundant role for MKP5 in limiting ROS production and preventing LPS‐induced vascular injury , 2009, The EMBO journal.

[104]  A. Fornace,et al.  The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway , 2005, Nature Immunology.

[105]  P. Bragado,et al.  Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. , 2009, Cancer research.

[106]  A. Ullrich,et al.  ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Lee Bardwell,et al.  Selectivity of Docking Sites in MAPK Kinases* , 2009, Journal of Biological Chemistry.

[108]  V. Sanders,et al.  Hematopoietic Protein Tyrosine Phosphatase Mediates β2-Adrenergic Receptor-Induced Regulation of p38 Mitogen-Activated Protein Kinase in B Lymphocytes , 2008, Molecular and Cellular Biology.

[109]  E. Vellenga,et al.  p38 MAP Kinase Inhibits Neutrophil Development Through Phosphorylation of C/EBPα on Serine 21 , 2009, Stem cells.

[110]  R. Medema,et al.  Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression , 2009, The EMBO journal.

[111]  M. Dell'Acqua,et al.  Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock , 2003, Nature Cell Biology.

[112]  M. Karin,et al.  Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex , 2008, Science.

[113]  P. Cohen,et al.  Feedback control of the protein kinase TAK1 by SAPK2a/p38α , 2003, The EMBO journal.

[114]  Jiahuai Han,et al.  Essential Role of p38γ in K-Ras Transformation Independent of Phosphorylation* , 2005, Journal of Biological Chemistry.

[115]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[116]  S. Y. Cajal,et al.  c‐Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin‐based therapy , 2008, International journal of cancer.

[117]  P. Muñoz-Cánoves,et al.  Transcriptional regulation by the p38 MAPK signaling pathway in mammalian cells , 2007 .

[118]  Luping Liu,et al.  The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha. , 2009, Acta crystallographica. Section D, Biological crystallography.

[119]  Christian Haslinger,et al.  p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway , 2007, Nature Genetics.

[120]  P. Cohen,et al.  Activation of the MAP kinase homologue RK requires the phosphorylation of Thr‐180 and Tyr‐182 and both residues are phosphorylated in chemically stressed KB cells , 1995, FEBS letters.

[121]  M. Benito,et al.  Negative regulation of Akt activity by p38alpha MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. , 2007, Cellular signalling.

[122]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[123]  Wendell A. Lim,et al.  The Ste5 Scaffold Directs Mating Signaling by Catalytically Unlocking the Fus3 MAP Kinase for Activation , 2009, Cell.

[124]  Roger J. Davis,et al.  Differential activation of p38MAPK isoforms by MKK6 and MKK3. , 2010, Cellular signalling.

[125]  G. Sumara,et al.  Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis , 2009, Cell.

[126]  I. Beis,et al.  ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. , 2006, Cellular signalling.

[127]  Elizabeth J. Goldsmith,et al.  Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket* , 1998, The Journal of Biological Chemistry.

[128]  Wei Guo,et al.  Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.

[129]  G. Kollias,et al.  Generation and Characterization of p38β (MAPK11) Gene-Targeted Mice , 2005, Molecular and Cellular Biology.

[130]  Jong-Sun Kang,et al.  A Cdo–Bnip-2–Cdc42 signaling pathway regulates p38α/β MAPK activity and myogenic differentiation , 2008, The Journal of cell biology.

[131]  J. Im,et al.  ATR-dependent Activation of p38 MAP Kinase Is Responsible for Apoptotic Cell Death in Cells Depleted of Cdc7* , 2008, Journal of Biological Chemistry.

[132]  P. Cohen,et al.  Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. , 1998, Chemistry & biology.

[133]  A. Doweyko,et al.  Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. , 2005, Current topics in medicinal chemistry.

[134]  J. Kurie,et al.  MKK4/SEK1 Is Negatively Regulated through a Feedback Loop Involving the E3 Ubiquitin Ligase Itch* , 2009, The Journal of Biological Chemistry.

[135]  Stuart Thomson,et al.  MSK2 and MSK1 mediate the mitogen‐ and stress‐induced phosphorylation of histone H3 and HMG‐14 , 2003, The EMBO journal.

[136]  Li Xing,et al.  Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. , 2009, Biochemistry.

[137]  Roger J. Davis,et al.  Role of the JIP4 Scaffold Protein in the Regulation of Mitogen-Activated Protein Kinase Signaling Pathways , 2005, Molecular and Cellular Biology.

[138]  H. Osada,et al.  p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. , 2005, Biochemical and biophysical research communications.

[139]  T. Yoshimura,et al.  Activation of Discoidin Domain Receptor 1 Facilitates the Maturation of Human Monocyte-Derived Dendritic Cells Through the TNF Receptor Associated Factor 6/TGF-β-Activated Protein Kinase 1 Binding Protein 1β/p38α Mitogen-Activated Protein Kinase Signaling Cascade , 2003, The Journal of Immunology.

[140]  Malgorzata Zakrzewska,et al.  Phosphorylation of Fibroblast Growth Factor (FGF) Receptor 1 at Ser777 by p38 Mitogen-Activated Protein Kinase Regulates Translocation of Exogenous FGF1 to the Cytosol and Nucleus , 2008, Molecular and Cellular Biology.

[141]  O. Livnah,et al.  p38alpha is active in vitro and in vivo when monophosphorylated at threonine 180. , 2009, Biochemistry.

[142]  H. Ichijo,et al.  The ASK1-MAP kinase cascades in mammalian stress response. , 2004, Journal of biochemistry.

[143]  C. Lepre,et al.  Crystal Structure of the P38α-MAPKAP Kinase 2 Heterodimer* , 2007, Journal of Biological Chemistry.

[144]  M. Goedert,et al.  p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP , 2005, The EMBO journal.

[145]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[146]  M. Gaestel,et al.  In the Cellular Garden of Forking Paths: How p38 MAPKs Signal for Downstream Assistance , 2002, Biological chemistry.

[147]  G. Johnson,et al.  MEKK4 Stimulation of p38 and JNK Activity Is Negatively Regulated by GSK3β* , 2007, Journal of Biological Chemistry.

[148]  Radha Akella,et al.  Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.

[149]  A. Cuenda,et al.  p38 MAP-kinases pathway regulation, function and role in human diseases. , 2007, Biochimica et biophysica acta.

[150]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[151]  P. Muñoz-Cánoves,et al.  Regulation of skeletal muscle gene expression by p38 MAP kinases. , 2006, Trends in cell biology.

[152]  M. Serrano,et al.  MSK2 Inhibits p53 Activity in the Absence of Stress , 2009, Science Signaling.

[153]  T. Lawrence,et al.  The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression , 2008, Nature Immunology.

[154]  Y. Yarden,et al.  p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.

[155]  C. Murga,et al.  Interfering with MAP Kinase Docking Interactions: Implications and Perspectives for the p38 Route , 2007, Cell cycle.

[156]  J. Brenton,et al.  Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. , 2002, Cancer Research.

[157]  Nobuyuki Tanaka,et al.  Mechanism of p38 MAP kinase activation in vivo. , 2003, Genes & development.

[158]  P. Cohen,et al.  The search for physiological substrates of MAP and SAP kinases in mammalian cells. , 1997, Trends in cell biology.

[159]  G. Hart,et al.  AMP-activated Protein Kinase and p38 MAPK Activate O-GlcNAcylation of Neuronal Proteins during Glucose Deprivation* , 2008, Journal of Biological Chemistry.

[160]  J. Hsuan,et al.  Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27 , 1994, Cell.

[161]  S. Shreeram,et al.  WIP1 phosphatase is a negative regulator of NF-κB signalling , 2009, Nature Cell Biology.

[162]  Michael Kracht,et al.  Peptides as signaling inhibitors for mammalian MAP kinase cascades. , 2009, Current pharmaceutical design.

[163]  C. Ambrosino,et al.  Differential Activation of p38 Mitogen-activated Protein Kinase Isoforms Depending on Signal Strength* , 2000, The Journal of Biological Chemistry.

[164]  W. Blackstock,et al.  Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.

[165]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[166]  Chen Dong,et al.  Differential involvement of p38 mitogen‐activated protein kinase kinases MKK3 and MKK6 in T‐cell apoptosis , 2002, EMBO reports.

[167]  E. Goldsmith,et al.  Yersinia YopJ Acetylates and Inhibits Kinase Activation by Blocking Phosphorylation , 2006, Science.

[168]  Yun-Wei Lin,et al.  ERK1/2 Achieves Sustained Activation by Stimulating MAPK Phosphatase-1 Degradation via the Ubiquitin-Proteasome Pathway* , 2003, Journal of Biological Chemistry.

[169]  Roger A. Davis,et al.  Nuclear Localization of p38 MAPK in Response to DNA Damage , 2009, International journal of biological sciences.

[170]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[171]  John A Tainer,et al.  The structure of the MAP2K MEK6 reveals an autoinhibitory dimer. , 2009, Structure.

[172]  Oscar Fernandez-Capetillo,et al.  p38 Mitogen-Activated Protein Kinase- and HuR-Dependent Stabilization of p21Cip1 mRNA Mediates the G1/S Checkpoint , 2009, Molecular and Cellular Biology.

[173]  D. Bulavin,et al.  WIP1 phosphatase at the crossroads of cancer and aging. , 2010, Trends in biochemical sciences.

[174]  N. Sharpless,et al.  p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. , 2009, Developmental cell.